Instructions for Nimesulide pills
English product name
Nimesulid
Release form
tab. 100 mg: 20 pcs.
Description:
Tablets 1 tab.
Nimesulide 100 mg
10 pcs - packages of box contour (2) - cardboard packs.
ATC codes
M01AX17 Nimesulide
Clinical-pharmacological groups / Group affiliation
NAPS. Selective COX-2 inhibitor
Active substance
Nimesulide
Pharmacotherapy group
NSAIDs
Testimony Nimesulide:
- Acute pain (back pain,
- lower back;
- pain syndrome in the musculoskeletal system,
- including bruising,
- ligament sprains and dislocated joints;
- tendinitis,
- bursitis;
- toothache);
- symptomatic treatment of osteoarthrosis (osteoarthritis) with pain syndrome;
- primary algodismenorrhea.
Method of use, course and dosage Nimesulide:
Inside 100 mg twice a day, after eating.
Application for kidney disorders
It is contraindicated in renal failure (QC less than 30 ml/min).
Use in liver disorders
It is contraindicated in moderate to severe liver failure.
Application in elderly patients
For external use, a doctor is required to monitor the condition of elderly patients with kidney, liver and congestive heart failure disorders.
Use in children
When used in paediatrics, the use of medicinal forms intended for children should be used.
- Nosology Nimesulide(ICD codes)
- K08.8
- Other refined changes of teeth and their support apparatus (including toothache)
- M05
- Seropositive rheumatoid arthritis
- M13.9
- Arthritis unspecified
- M15
- Polyarthrosis
- M19.9
- Arthrosis unspecified
- M25.5
- Joint pain
- M42
- Spinal osteochondrosis
- M54
- Dorsalgia
- M54.1
- Radikulopathy
- M54.3
- Ishias
- M54.4
- Lumbago with Sciatica
- M65
- Synovitis and tenosinovites
- M70
- Soft tissue diseases related to load, overload and pressure
- M71
- Other bursopathy
- M79.0
- Rheumatism unspecified
- M79.1
- Mialgia
- N94.4
- Primary dysmenorrhea
- R52.0
- Acute pain
- R52.2
- Other persistent pain (chronic)
- T14.0
- Superficial injury of an unspecified area of the body (including abrasion, bruising, bruising, hematoma, bite of a non-venomous insect)
- T14.3
- Dislocation, stretching and overtension of the capsule-bonding apparatus of the unspecified body region joint
Pharmacological effect:
NSAIDs from the sulfonanilide class, a selective competitive reversible inhibitor of COX-2. It has anti-inflammatory, analgesic and antipyretic effects. It has a less pronounced oppressive effect on COX-1.
